Publication

A glimpse into the future of model-informed drug discovery and development

Explore the future of Model-Informed Drug Development (MIDD), including advances in pharmacometrics, PBPK, QSP, precision…

Certara2026 年 8 月 28 日

Publication

Refinement of Operating Characteristics for Model-Based TGI Metrics Decision Support to Ungate a Pivotal Trial in Oncology

Explore how model-based tumor growth inhibition metrics can support earlier Go/No-Go decisions and pivotal trial…

Certara2026 年 8 月 28 日

Blog

Why pharmacometrics automation is the foundation of modern PK/PD

Pharmacometrics automation is reshaping PK/PD workflows. Explore five principles driving AI, cloud infrastructure, and model…

Sebastian Kuechenmeister2026 年 8 月 28 日

Blog

The five drug development questions that bring sponsors to pharmacometrics

Sponsors rarely come to pharmacometrics because they need a model. They come with a development…

Rik de Greef2026 年 8 月 24 日

Blog

A model-informed approach to radioligand therapy dosing under Project Optimus

Explore how targeted radionuclide therapy dosing uses QSP, biologically effective dose (BED), and exposure-response modeling…

Hunter Stephens, PhD2026 年 8 月 13 日

Blog

RsNLME meets MCP: the pharmacometric AI assistant scientists have been asking for

Discover RsNLME's new MCP server: an AI assistant that understands both pharmacometric science and PML/R…

Arjen Bos2026 年 8 月 3 日

Publication

Advances and Challenges in Model-Informed Precision Dosing of Antimicrobials for Pediatric Patients

Explore advances in model-informed precision dosing (MIPD) for pediatric antimicrobial therapy, including population PK modeling,…

Certara2026 年 7 月 29 日

Poster

Assessing Cross-Version Simcyp Simulator Prediction Performance Using a Bioequivalence Framework to Support EMA Qualification

See how Simcyp Simulator V20–V24 DDI predictions were shown equivalent to the EMA-qualified V19 using…

Certara2026 年 7 月 24 日

Blog

Important drug development questions that model-based meta-analysis answers

Explore drug development questions that model-based meta-analysis answers, from competitive positioning to dose selection &…

Matt Zierhut, PhD MBA2026 年 7 月 23 日

Live Events

Phoenix Roadshow 2026 – Tokyo

Certara2026 年 7 月 21 日

临床药理学

A glimpse into the future of model-informed drug discovery and development

Refinement of Operating Characteristics for Model-Based TGI Metrics Decision Support to Ungate a Pivotal Trial in Oncology

Why pharmacometrics automation is the foundation of modern PK/PD

The five drug development questions that bring sponsors to pharmacometrics

A model-informed approach to radioligand therapy dosing under Project Optimus

RsNLME meets MCP: the pharmacometric AI assistant scientists have been asking for

Advances and Challenges in Model-Informed Precision Dosing of Antimicrobials for Pediatric Patients

Assessing Cross-Version Simcyp Simulator Prediction Performance Using a Bioequivalence Framework to Support EMA Qualification

Important drug development questions that model-based meta-analysis answers

Phoenix Roadshow 2026 – Tokyo

订阅时事通讯

快捷链接

解决方案

联系我们